A Neuropsychiatric Prelude to Unveiling Small Cell Lung Cancer with Suspected Paraneoplastic Limbic Encephalitis: A Case Report

Jessa Letargo(Western University), Enxhi Kotrri(Western University), Alexander V. Louie(London Health Sciences Centre), M. Sara Kuruvilla(Western University), Timothy K. Nguyen(Western University), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University)

Current Oncology

June 19, 2025

10.3390/curroncol32060366

Cited by 2

Related Papers

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

|The Lancet|2019|1.9k

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

|The Lancet Oncology|2017|1.8k

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

|Journal of Clinical Oncology|2020|1.3k

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

|Journal of Clinical Oncology|2019|1.3k

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

|The Lancet Oncology|2016|1.1k